Will any medication be approved for Long Covid/PASC in any Western country before 2026?
➕
Plus
17
Ṁ3273
2026
43%
Any treatment
37%
Metformin
29%
Maraviroc
28%
Naltrexone
25%
Aripiprazole
22%
Rapamycin
18%
Baricitinib
17%
Piracetam
17%
Pyridostigmine
16%
Prednisolone
16%
Any antiviral mAb
15%
Mitodicure MDC002
13%
Ampligen
13%
Triple anticoagulants
9%
AER002
6%
Paxlovid
2%
Temelimab

Will resolve as Yes if any medication receives full approval or emergency approval or in any way receives an indication for' a significant portion of Long Covid and/or ME/CFS patients, in any of the following countries:

- USA

- UK

- Canada

- Australia

- New Zealand

- Any country in the European Free Trade Association (EU + Norway, Switzerland, Iceland, Liechtenstein)

Get
Ṁ1,000
and
S3.00
Sort by:
bought Ṁ5 NO

“or in any way becomes legally available to a significant portion” if this is your definition. Then Naltrexone should resolve to yes.

Hmm yes, that's not the intention of this question, because it's off-label and already available. (Technically, other medications like triple anticoagulants can also be prescribed off-label)

I will change it to: 'or in any way receives an indication for' a significant portion of Long Covid and/or ME/CFS patients.

Would mayo clinic proceedings having it in the list of ME/CFS meds count. Or for the US, only FDA approval counts?

Only FDA approval

© Manifold Markets, Inc.Terms + Mana-only TermsPrivacyRules